| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/06/2013 | CA2584338C Gabapentin prodrug sustained release oral dosage forms |
| 08/06/2013 | CA2570313C Drug delivery product and methods |
| 08/06/2013 | CA2569513C Preformulation for liquid crystalline phase structure |
| 08/06/2013 | CA2568501C Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance |
| 08/06/2013 | CA2564962C Pharmaceutical tablets comprising two or more unitary segments |
| 08/06/2013 | CA2556450C Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof |
| 08/06/2013 | CA2556305C Rapidly dissolving solid oral dosage form for delivery of composition for increasing nitric oxide activity |
| 08/06/2013 | CA2540308C Drug coating providing high drug loading and methods for providing the same |
| 08/06/2013 | CA2540059C Controlled release formulations exhibiting an ascending rate of release |
| 08/06/2013 | CA2477075C Pharmaceutical and cosmetic compositions comprising plgf-1 |
| 08/06/2013 | CA2458016C Paper product with disinfecting properties |
| 08/06/2013 | CA2451839C Pharmaceutical compositions comprising peptides and permeation enhancers |
| 08/06/2013 | CA2358385C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 08/03/2013 | CA2805471A1 Slow release pharmaceutical compound of trimetazidine |
| 08/01/2013 | WO2013113024A1 Lyophilized platelet lysates |
| 08/01/2013 | WO2013112806A2 Transdermal hormone delivery |
| 08/01/2013 | WO2013112804A1 Formulations of 3-(6-(1-(2.2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 08/01/2013 | WO2013112762A1 Bendamustine compositions and methods therefore |
| 08/01/2013 | WO2013112734A1 Sustained drug delivery from solid implants with nanochannel membranes |
| 08/01/2013 | WO2013112617A1 Hollow drug-filled stent and method of forming hollow drug-filled stent |
| 08/01/2013 | WO2013112491A1 Tunable hydrogel materials and methods for preparing the same |
| 08/01/2013 | WO2013112456A1 Controlled release formulations for the induction and proliferation of blood cells |
| 08/01/2013 | WO2013112434A1 Time released biodegradable or bioerodible microspheres or microparticles suspended in a solidifying depot-forming injectable drug formulation |
| 08/01/2013 | WO2013112215A1 Synthesis, dye functionalization and bioimaging of polymeric nanocapsules |
| 08/01/2013 | WO2013111817A1 Oil-in-water-type creamy composition containing tacrolimus |
| 08/01/2013 | WO2013111149A1 Controlled release solid oral compositions of dexlansoprazole |
| 08/01/2013 | WO2013111147A1 Extended release compositions of nevirapine |
| 08/01/2013 | WO2013111100A1 Stable amorphous raltegravir potassium premix and process for the preparation thereof |
| 08/01/2013 | WO2013111070A1 In-situ multilayered tablet technology |
| 08/01/2013 | WO2013110975A1 Improved nitazoxanide composition and preparation method thereof |
| 08/01/2013 | WO2013110956A1 Improved injections |
| 08/01/2013 | WO2013110812A1 Composition in the form of a gel capsule comprising ginger powder and a coating agent |
| 08/01/2013 | WO2013110789A1 Drug/carrier inclusion composites prepared by a mechanochemical activation process using high-energy fluid-jet mills |
| 08/01/2013 | WO2013110756A1 Ingenol mebutate in combination with cryotherapy for the treatment of actinic keratosis |
| 08/01/2013 | WO2013110644A1 Pharmaceutical composition containing crystalline sorafenib tosylate |
| 08/01/2013 | WO2013110632A1 Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation |
| 08/01/2013 | WO2013110621A1 Stabilised protein compositions based on semifluorinated alkanes |
| 08/01/2013 | WO2013110567A1 Novel orally administered dabigatran formulation |
| 08/01/2013 | WO2013110442A1 Thin film drug delivery system for the transmucosal administration of a 1,4- benzoquinone derivative |
| 08/01/2013 | WO2013110354A1 Compositions and methods for cell transplantation |
| 08/01/2013 | WO2013110340A1 Edible slow dissolving film for treating oral ulcerations |
| 08/01/2013 | WO2013075105A3 Tcl1 peptides for immunotherapy |
| 08/01/2013 | WO2013071456A3 Injectable veterinary composition for sustained release of ceftiofur and florfenicol in animal species, which comprises poly(lacticcoglycolic acid) (plga) microparticles, and the method for the preparation thereof |
| 08/01/2013 | WO2013055302A9 Effervescent composition comprising n-acetylcysteine and doxophylline or theophylline |
| 08/01/2013 | WO2013055058A3 Antibody-binding peptide-ferritin fusion protein and uses thereof |
| 08/01/2013 | WO2013054178A3 Extended release pharmaceutical compositions containing carmabazepine |
| 08/01/2013 | WO2013042125A3 Nano delivery systems for sirna |
| 08/01/2013 | US20130197210 Complexing agents for compositions containing inclusion complexes |
| 08/01/2013 | US20130197126 Paste-Like Bone Cement |
| 08/01/2013 | US20130197105 Dpi formulation containing sulfoalkyl ether cyclodextrin |
| 08/01/2013 | US20130197103 Composition and method for the enhancement of the efficacy of drugs |
| 08/01/2013 | US20130197100 Colloidal nanoscale carriers for active hydrophilic substances and method for producing same |
| 08/01/2013 | US20130197099 Partially absorbable fiber-reinforced composites for controlled drug delivery |
| 08/01/2013 | US20130197098 Composition in form of a gel for the virucidal disinfection of mammalian skin |
| 08/01/2013 | US20130197092 Novel Non-Aqueous Topical Solution of Diclofenac and Process for Preparing the Same |
| 08/01/2013 | US20130197051 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 08/01/2013 | US20130197036 Transdermal absorption preparation |
| 08/01/2013 | US20130197024 Liquid formulations for treatment of diseases or conditions |
| 08/01/2013 | US20130197021 Combination of active loaded granules with additional actives |
| 08/01/2013 | US20130197020 Method of Providing Sustained Analgesia With Buprenorphine |
| 08/01/2013 | US20130197006 Non-Starch Based Soft Chewables |
| 08/01/2013 | US20130197005 Parenteral Formulations Of Dopamine Agonists |
| 08/01/2013 | US20130196963 Topical steroidal formulations |
| 08/01/2013 | US20130196954 Method of treating acne |
| 08/01/2013 | US20130196849 Substituted Cellulose Acetates and Uses Thereof |
| 08/01/2013 | US20130195988 Vascular embolization gelling agent for sustained release of drugs for treating tumors and method for preparing the same |
| 08/01/2013 | US20130195986 New Particles of Tetracyclines and Protecting Agent |
| 08/01/2013 | US20130195983 Nanoparticle formulations and uses thereof |
| 08/01/2013 | US20130195982 Non-abusable pharmaceutical composition comprising opioids |
| 08/01/2013 | US20130195981 Non-abusable pharmaceutical composition comprising opioids |
| 08/01/2013 | US20130195980 Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and crohn's disease |
| 08/01/2013 | US20130195978 Darunavir Compositions |
| 08/01/2013 | US20130195977 Low Concentration Meloxicam Tablets |
| 08/01/2013 | US20130195976 Pharmaceutical composition for the treatment of acute disorders |
| 08/01/2013 | US20130195975 In vivo use of water absorbent polymers |
| 08/01/2013 | US20130195974 Ph-dependent gradual release pharmaceutical composition |
| 08/01/2013 | US20130195970 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 08/01/2013 | US20130195969 Small liposomes for delivery of immunogen encoding rna |
| 08/01/2013 | US20130195968 Virion-like delivery particles for self-replicating rna molecules |
| 08/01/2013 | US20130195965 Method for formulating large diameter synthetic membrane vesicles |
| 08/01/2013 | US20130195964 Compositions and Methods for the Treatment of Cancer |
| 08/01/2013 | US20130195963 Mesoporous silicon particles for the presentation of tumor antigens and adjuvant for anti-cancer immunity |
| 08/01/2013 | US20130195962 Lipid membrane structure |
| 08/01/2013 | US20130195960 Substituted Cellulose Acetates and Uses Thereof |
| 08/01/2013 | US20130195959 Lyophilized platelet lysates |
| 08/01/2013 | US20130195957 Patch and method for enhancing adhesion force of the same |
| 08/01/2013 | US20130195956 Transdermal Hormone Delivery |
| 08/01/2013 | US20130195955 Implants Containing BMP-7 |
| 08/01/2013 | US20130195953 Methods and formulations for administration of anti-inflammatory compounds |
| 08/01/2013 | US20130195952 Extended or continuous wear silicone hydrogel contact lenses for the extended release of comfort molecules |
| 08/01/2013 | US20130195951 Heterogeneous implantable devices for drug delivery |
| 08/01/2013 | US20130195950 Heterogeneous implantable devices for drug delivery |
| 08/01/2013 | US20130195939 Methods and compositions for oral administration of exenatide |
| 08/01/2013 | US20130195938 Method of modifying dissolution rate of particles by addition of hydrophobic nanoparticles |
| 08/01/2013 | US20130195937 Use of carbon nanotubes for preventing or treating brain disease |
| 08/01/2013 | US20130195936 Ophthalmic oil-in-water emulsions containing prostaglandins |
| 08/01/2013 | US20130195934 Methods and devices for providing prolonged drug therapy |
| 08/01/2013 | US20130195933 Pharmaceutical composition and use |
| 08/01/2013 | US20130195923 Microemulsions with adsorbed macromolecules and microparticles |
| 08/01/2013 | US20130195898 Microemulsions with adsorbed macromolecules and microparticles |